Scholars Central

CommentaryPublished 29 Apr 2025

Goserelin: Broad Clinical Applications and Benefits

Authors: Sophia N. Lee

Department of Precision Diagnostics, Starlight Oncology Center, USA

Insights in Gynecologic Oncology

Volume 10 · Issue 2 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Goserelin acetate is a critical therapeutic agent in hormone-sensitive cancers and gynecological conditions. In early breast cancer, it significantly improves disease-free survival and reduces relapse when combined with adjuvant endocrine therapy or neoadjuvant chemotherapy. It offers ovarian protection for young cancer patients and is effective for endometrial ablation, myomectomy, and endometrial polyps. Goserelin also plays a key role in prostate cancer management. These findings collectively establish goserelin as a versatile and impactful treatment, enhancing patient outcomes across a spectrum of clinical applications with a favorable safety profile.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Insights in Gynecologic Oncology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInsights in Gynecologic Oncology
  • SubjectOncology & Cancer
  • SubjectReproductive Medicine & Gynaecology
  • BylineArticles whose byline prints “Sophia N. Lee”